Skip to main content

Erratum to: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase

The Original Article was published on 22 August 2013

It has been drawn to the publisher’s attention that this article [1] was inadvertently published with certain omissions. The authors apologize for the omissions in the published article.

The co-authors Nicolas Sluis-Cremer and Brian D. Herman, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA have now been added as co-authors.

The following sentence has been added to the acknowledgements section: “The research in the N.S.–C laboratory was supported by a grant from the United States of America National Institutes of Health (GM068406)”

References

  1. Penta , et al.: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase. Organic and Medicinal Chemistry Letters 2013, 3: 8. 10.1186/2191-2858-3-8

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sankaran Murugesan.

Additional information

The online version of the original article can be found at 10.1186/2191-2858-3-8

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Penta, A., Ganguly, S. & Murugesan, S. Erratum to: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase. Org Med Chem Lett 3, 12 (2013). https://doi.org/10.1186/2191-2858-3-12

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/2191-2858-3-12